Skip to main content

Day: December 8, 2025

UPDATE — Prospect Enhanced Yield Fund Announces 9.0% Annualized Total Cash Distribution Rate (on Net Asset Value) for October 2025 through December 2025

NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — Prospect Enhanced Yield Fund (“PENF” or the “Fund”) announced today that the Fund’s Board of Directors has declared monthly cash shareholder distributions for October 2025, November 2025, and December 2025. These distributions represent the first, second, and third monthly distributions paid by the Fund. The annualized total cash distribution is $2.28 per share (9.0% annualized rate based on the October 20, 2025 net asset value), for distributions with record dates between October 30, 2025 and December 30, 2025 based on the current net asset value of $25.29 per common share.  The cash distribution will have monthly record dates and will be payable monthly to common stockholders of record at the close of business each month. These declared distributions equal $0.57 on a quarterly basis...

Continue reading

Gold Royalty Announces Upsizing of Previously Announced Bought Deal Financing

BASE SHELF PROSPECTUS AND PRELIMINARY PROSPECTUS SUPPLEMENT ACCESSIBLE AND FINAL PROSPECTUS SUPPLEMENT TO BE ACCESSIBLE WITHIN TWO BUSINESS DAYS ON SEDAR+ VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) — Gold Royalty Corp. (“Gold Royalty” or the “Company”) (NYSE American: GROY) is pleased to announce that as a result of excess demand, it has agreed with National Bank Capital Markets, BMO Capital Markets, and RBC Capital Markets as joint bookrunners, on behalf of a syndicate of underwriters (collectively, the “Underwriters”) to increase the size of its previously announced bought deal financing. Gold Royalty will now issue 22,500,000 common shares of the Company (the “Common Shares”) at a price of US$4.00 per Common Share (the “Offering Price”) for aggregate gross proceeds of US$90.0 million (the “Offering”). The Company...

Continue reading

Miata Metals Announces Closing of $11.5 Million Public Offering Including Full Exercise of the Over-Allotment Option

Not for distribution to United States newswire services or for dissemination in the United States VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) — Miata Metals Corp. (CSE:MMET) (FSE: 8NQ) (OTCQB: MMETF) (“Miata” or the “Company”) is pleased to announce that it has closed its previously announced short form prospectus offering (the “Offering”) of common shares of the Company (“Common Shares”). The Company issued a total of 23,958,500 Common Shares at a price of $0.48 per share for gross proceeds of $11,500,080, inclusive of the full exercise of the over-allotment option. The Common Shares were offered by way of a short form prospectus dated December 3, 2025 (the “Prospectus”) filed with the securities regulatory authorities in each of the provinces of Canada, other then the province of Québec, and in such other jurisdictions...

Continue reading

Jiuzi Holdings Inc. Announce Reverse Split Record Date

HANGZHOU, China, Dec. 08, 2025 (GLOBE NEWSWIRE) — Jiuzi Holdings Inc. (NASDAQ: JZXN; the “Company” or “JZXN”),  a leading new energy vehicle (NEV) dealership group operating under the brand name “Jiuzi” in China is reporting that its board of directors has approved a reverse stock split (the “Reverse Stock Split”) of the Company’s ordinary shares, a par value of US$0.00195 each (the “Ordinary Shares”), at a ratio of 1-for-40, with a post-Reverse Stock Split par value of US$0.078. The Company is undertaking the Reverse Stock Split with the objective of meeting the minimum $1.00 per Ordinary Share bid requirement for maintaining the listing of the Ordinary Shares on The Nasdaq Capital Market. The Reverse Stock Split will be effective at 04:01 p.m. (ET) on Wednesday, December 10, 2025 (the “Record Date”) and the Ordinary Shares will...

Continue reading

Schouw & Co. share buy-back programme, week 49 2025

On 5 May 2025, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 20 of 2 May 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 120 million during the period 5 May to 31 December 2025. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount    Accumulated until 28 November 2025 196,200 597.51 117,231,745    Monday, 1 December 2025 600 609.41 365,646    Tuesday, 2 December 2025 400 614.38 245,752    Wednesday, 3 December 2025 400 623.50 249,400    Thursday, 4 December 2025 400 621.84 248,736    Friday,...

Continue reading

Xanadu Expands Partnership with A*STAR to Advance Photonic Quantum Computing

Strategic agreement broadens Xanadu’s presence in Singapore TORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) — Xanadu Quantum Technologies Inc. (“Xanadu”), a leading photonic quantum computing company, today announced it has signed a Memorandum of Understanding (“MoU”) with the Agency for Science, Technology and Research (“A*STAR”) in Singapore. This agreement builds on Xanadu’s existing partnership with A*STAR Institute of Microelectronics (A*STAR IME) and extends to include the A*STAR Institute of High Performance Computing (A*STAR IHPC) and A*STAR Quantum Innovation Centre (A*STAR Q.InC). Together, Xanadu and A*STAR intend to advance research and development in quantum technologies, with the goal of establishing long-term research collaborations and exploring the potential of creating joint quantum laboratories and operations in Singapore. Quantum...

Continue reading

Intercont (Cayman) Limited Announces Strategic Acquisition of Singapore-Based Web3 Innovator Starks Network Ltd, Strengthening Its Position in On-Chain Digital Asset Infrastructure

HONG KONG, Dec. 08, 2025 (GLOBE NEWSWIRE) — Intercont (Cayman) Limited (Nasdaq: NCT)(“NCT” or “the Group”), a global carbon-neutral shipping company, announced that, it has entered into a Memorandum of Understanding (MOU) to acquire a less than 50% minority stake of Starks Network Ltd (“Starks Network” or “the Company”) , a leading Singapore-based Web3 technology service provider and will co-develop the Project zCloak Network (“zCloak”). This strategic agreement marks a significant milestone, positioning NCT and zCloak to jointly advance the integration of maritime services and blockchain technology. Starks Network, incorporated in the Cayman Islands with operational headquarters in Singapore, has established strong competitive advantages in the global Web3 ecosystem with Project zCloak Network. The company’s proprietary frameworks...

Continue reading

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Data Demonstrate Potent in vivo Gene Editing of Hematopoietic Stem Cells (HSCs) in the Bone Marrow with Systemic Delivery in Preclinical Murine Models Using Fusogen Technology  Broadens Application of Fusogen Technology Beyond T Cells to Second Cell Type, HSCs, Showing Potent and Specific in vivo Delivery Underscores Ability of Fusogen Technology to Deliver Diverse Payloads, including CRISPR Gene-Editing and Base-Editing Machinery Highlights Potential of Fusogen Platform in Diseases like Sickle Cell Disease and Beta Thalassemia Without the Need for Conditioning Chemotherapy Sana is Incorporating its Fusogen Technology to Develop SG293, a CD8-targeted Fusosome that Makes CD19-directed CAR T Cells in vivo; Expects to File IND for SG293 in B-cell Cancers and/or B-cell Mediated Autoimmune Diseases as Early as 2027 SEATTLE, Dec. 08, 2025...

Continue reading

Polyrizon Completes FDA Pre-Submission Meeting for PL-14 Allergy Blocker Nasal Spray

Ra’anana, Israel, Dec. 08, 2025 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today announces that it has successfully completed a pre-submission meeting with the U.S. Food and Drug Administration (FDA) regarding its PL-14 Allergy Blocker product, a novel nasal spray designed to provide protective intranasal barrier functionality. During the meeting, Polyrizon presented the general development program plan for PL-14, including the proposed manufacturing process, analytical and quality controls, and the structure of the stability program that will support future regulatory submissions. The Company also reviewed its planned biocompatibility assessment package and additional preclinical studies aligned with the FDA’s “Guidance...

Continue reading

Black Hills Corp. Requests Rate Review in Arkansas

RAPID CITY, S.D., Dec. 08, 2025 (GLOBE NEWSWIRE) — Black Hills Corp. (NYSE: BKH) today announced that its Arkansas natural gas utility has filed a rate review application with the Arkansas Public Service Commission requesting $29.4 million in new annual revenue to recover the necessary capital infrastructure and operational costs required to deliver safe, reliable natural gas service for over 189,000 Arkansas customers in more than 100 communities in Arkansas. The company is seeking recovery of approximately $147 million in safety, reliability and system integrity investments for its natural gas pipeline infrastructure since its last general rate filing in 2023. These critical investments are required to meet system growth, ensure the safe and reliable delivery of natural gas to customers’ homes and businesses, and meet compliance...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.